Search results

Narrow your search

Result types

Showing 321 - 330 of 781 for "New Zealand" with applied filters

News & Analysis

Analysis of the First Applications of the Serious Accidents Punishment Act

21 June 2023 by Jipyong - South Korea

The Serious Accidents Punishment Act (“SAPA”) is a relatively new legislation that came into force on January 27, 2022.

News & Analysis

Latest Update to “Guidelines for Workplace Risk Assessment“ to Impact Businesses in Korea

31 May 2023 by Lee & Ko - South Korea

On 22 May 2023, the Ministry of Employment and Labor (MOEL) announced a significant update to its “Guidelines for Workplace Risk Assessment“ (Guidelines), effective immediately.

News & Analysis

Supreme Court of Korea Affirms Abuse of Dominance for Tying Patent Licenses and Engineering Services in the Shipbuilding Industry

30 May 2023 by Lee & Ko - South Korea

Lee & Ko’s Antitrust & Competition Group successfully represented three major Korean shipbuilding companies in the court action involving Gaztransport & Technigaz SA (GTT), the exclusive holder of key patents in technology for manufacturing/constructing membrane storage tanks used on liquefied natural gas carriers (LNG Carrier).

News & Analysis

Revisiting 101 rule of Transfer Pricing in Indonesia

29 May 2023 by ABNR - Indonesia: Freddy Karyadi, Anastasia Irawati

As one of the designated Key Partners of the OECD, Indonesia has implemented some of the OECD’s Action Plans into its prevailing laws and regulations, including Action 8-10 concerning Transfer Pricing and Action 13 concerning Country-by-country Reporting.

News & Analysis

Advised on MBK Partners’ KRW 2.5 Trillion Acquisition of Leading Global Dental Scanner Developer Medit Corporation from UCK Partners

25 May 2023 by Kim & Chang - South Korea

Kim & Chang, using separate teams, advised both the buyer, MBK Partners, and the sellers, UCK Partners (formerly known as Unison Capital Korea) and individual shareholders, in connection with the purchase and sale of Medit Corporation (the “Target Company”).

News & Analysis

Patenting Molecular Diagnostics

17 May 2023 by LexOrbis - DPS Parmar

The patent eligibility in every jurisdiction differs in content and form. It perhaps finds its justification in the stage of development the country is placed in relation to inventions of new technology or its adoption by the state technology groups.

News & Analysis

LexOrbis Successfully Hosts 5th edition of the AIPLA Women in IP Global Networking Event 2023

09 May 2023 by LexOrbis - India

On April 28, 2023, the India Habitat Centre in New Delhi was abuzz with over 100+ women professionals from different segments, all in attendance for the Women in IP Global Networking Event 2023 hosted by LexOrbis on behalf of the American Intellectual Property Law Association (AIPLA).

News & Analysis

Enforcement of Arbitral Awards in Korea and Interplay with the Korean Fair Trade Act

25 April 2023 by Jipyong - South Korea

A recent decision by the German Federal Court of Justice has spurred interest in the international arbitration community regarding the interplay between a country’s antitrust laws and enforcement of foreign arbitral awards.

News & Analysis

Listing in Hong Kong of a World Bank catastrophe bond

21 April 2023 by LC Lawyers - Rossana Chu (Managing partner)

Hong Kong has taken another step in developing the city as a leading international risk management center. On 28 March 2023, a US$350 million World Bank catastrophe bond was listed on the Hong Kong Stock Exchange .

News & Analysis

Product Hopping and Ever-Greening of Patents in India

20 April 2023 by LexOrbis - Arun Kumar (Managing associate)

The Indian pharmaceutical market is one of the largest markets in the globe, both in terms of production and consumption. Several changes have been made to the patent and competition law due to the increasing challenges in the pharmaceutical market that directly impact the profit margin of pharmaceutical manufacturers. To increase these margins, pharmaceutical product manufacturing firms employ a variety of strategies. This article investigates the concept of “product hopping” and compares it with the practice of patent evergreening.